BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17380066)

  • 1. Current treatment approaches in diabetic macular edema.
    Meyer CH
    Ophthalmologica; 2007; 221(2):118-31. PubMed ID: 17380066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
    Browning DJ; Fraser CM; Powers ME
    Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on treatments for diabetic macular edema.
    Fraser-Bell S; Kaines A; Hykin PG
    Curr Opin Ophthalmol; 2008 May; 19(3):185-9. PubMed ID: 18408491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW; Park SC; Cho HY; Kang JH
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
    Figueroa MS; Contreras I; Noval S
    Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
    Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
    Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Nohutcu AF; Horozoglu F; Celik E
    Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Er H
    Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
    [No Abstract]   [Full Text] [Related]  

  • 11. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is removal of internal limiting membrane always necessary during surgery for refractory diffuse diabetic macular edema without evident epimacular proliferation?].
    Aboutable T
    Klin Monbl Augenheilkd; 2006 Aug; 223(8):681-6. PubMed ID: 16927225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Horozoglu F; Celik E; Nohutcu AF
    Retina; 2007 Jun; 27(5):557-66. PubMed ID: 17558316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pars plana vitrectomy for refractory diabetic macular edema.
    Grigorian R; Bhagat N; Lanzetta P; Tutela A; Zarbin M
    Semin Ophthalmol; 2003 Sep; 18(3):116-20. PubMed ID: 15513471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined surgical and pharmacological treatment of diabetic maculopathy].
    Robaszkiewicz J; Chmielewska K; Wierzbowska J; Figurska M; Frontczak-Baniewicz M; Stankiewicz A
    Klin Oczna; 2010; 112(1-3):19-23. PubMed ID: 20572497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing paradigms in the treatment of diabetic retinopathy.
    El-Asrar AM; Al-Mezaine HS; Ola MS
    Curr Opin Ophthalmol; 2009 Nov; 20(6):532-8. PubMed ID: 19644368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Ho TC; Lai WW; Lam DS
    Am J Ophthalmol; 2006 Apr; 141(4):786-7; author reply 787-8. PubMed ID: 16564847
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Sarici A; Muftuoglu G
    Am J Ophthalmol; 2006 Apr; 141(4):785-6; author reply 786. PubMed ID: 16564845
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiopathy and the eye].
    Rencová E
    Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.